No, the relationship with Eisai started after Clarity AD had been planned and the tests for this trial were old school pencil &paper. However they are thought to be working on the Lecanemab subcutaneous trial and the cessation and maintenance regimen trials. It it also confirmed they worked on Lilly's Trailblazer Phase 3.
No, the relationship with Eisai started after Clarity AD had...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CGS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
0.005(0.52%) |
Mkt cap ! $167.5M | |||
| Open | High | Low | Value | Volume |
| 96.5¢ | 97.0¢ | 96.5¢ | $32.37K | 33.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 9220 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 561 | 4 |
View Market Depth
| Last trade - 12.47pm 12/11/2024 (20 minute delay) ? |
| CGS (ASX) Chart |